A global study of a combination drug therapy, led by an investigator at Huntsman Cancer Institute, has shown improved overall survival rates for metastatic prostate cancer compared to standard treatments.
Explore prostate cancer treatment options like surgery, radiation, and hormone therapy. Learn how to choose the best approach with your healthcare provider’s guidance and support.
The chance of getting prostate cancer increases with age but genetics can also be a risk factor. Huntsman Cancer Institute genetic counselor Sam Beck answers questions about prostate cancer.
A virtual support group provides a way for members to openly share struggles, find emotional support, and learn coping techniques from experts, creating a unique brotherhood.
From shrinking brain tumors to personalized therapies, our investigators are leading pioneering research, discovering breakthroughs in treatment, and promoting equity-driven care.
The Society of Huntsman Translational Scholars adds Umang Swami, MD, MS, and Matthew Covington, MD, to its cohort that advances cancer testing and treatments through financial support and collaboration.
Two visionary physician leaders take pivotal new roles to amplify innovation and patient-centric advancements in Huntsman Cancer Institute’s quest for a future free from cancer.
Investigators have been awarded a grant to find a better way to protect muscle mass in patients. Muscle mass plays a critical role in quality of life and cancer survival.
Researchers find way to decrease cancer deaths among Black people, begin new lung cancer clinical trial, use app to help people manage cancer, and employ games to reduce chemotherapy after-effects.
Read how scientists reduce infection risk after pancreatic surgery, discover the best cost-effective treatment for prostate cancer, learn which lung cancer patients have the most emergency department visits, and more.
In 2011, Lowry Bushnell was given a life-changing diagnosis and just years to live. After meeting with Dr. Tward, his hope and future were restored. Now, the cancer is gone...
The combination of two oral medications has shown positive results in people with prostate cancer, whose disease has spread to other parts of the body. Compared with XTANDI plus placebo...
Read how researchers discovered genetic markers that hinder pancreatic cancer treatment and mutations that increase sarcoma risk. Then learn how artificial intelligence is helping predict prostate cancer outcomes and see...
Huntsman Cancer Institute celebrates the addition of two endowed chair holders and a fellowship, as well as the renewal of two esteemed endowed chairs. CEO Mary Beckerle, PhD, congratulates distinguished...
Following Gary Canham's passing his grandson wanted to honor his legacy of resourcefulness and giving. Through a state program, he gave his grandfather's unused, sealed cancer medicine to patients at...
